Iambic Therapeutics, Inc.
IAM · NasdaqClose, 2026-10-29Close, 2026-10-29 · source: Databento · USD · figures not investment advice Window -24.5%vs low +2.0%vs high -40.0%
Pricethrough 2026-10-29ex-date (0) · fiscal quarter (0)
Dividends: company filings (SEC EDGAR) and the historical exchange record.
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Valuation & key statistics
Valuation under review.
Financials · latest year
Financial summary not available yet.